METABOLOMIC PROFILING SHOWS MORE LIPID ABNORMALITIES IN NNRTI COMPARED TO InSTI USERS
Background: Integrase strand transfer inhibitors (INSTI) are associated with weight gain, in contrast to the also commonly used non-nucleoside reverse transcriptase inhibitors (NNRTI). Plasma metabolomic and lipoprotein profile of INSTI and NNRTI users was therefore compared. Methods: The present study has a two-phase design and includes a discovery and validation cohort of INSTI and NNRTI…